identified CD8+ Tpex in uninvolved lymph nodes of head and neck squamous cell carcinoma patients, which are clonally related to tumor‐resident terminal Tex.[144] Following ICI treatment, the Tpex population decreases and clusters near DCs, suggesting activation. The gene discussed is CD8A; the disease is neoplasm.